Protocol No
ARCELLX-ACLX-001-DDBCMA
Principal Investigator
Binod Dhakal
Phase
I
Summary
This project is being done to study the effects of treatment with SPRX001 protein and ARC-T cells for the treatment of relapsed/refractory multiple myeloma.
Description
Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category
ClinicalTrials.gov